Novartis Investigative Site

Nuoro, NU 08100

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Chronic Myelogenous Leukemia

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed